Rekombinanter CD274 (Atezolizumab Biosimilar) Antikörper

Produktnummer ABIN6964422

Produktdetails anti-CD274 (Atezolizumab Biosimilar) Antikörper

Target: CD274 (Atezolizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Humanized

Klonalität: Monoklonal

Konjugat: Dieser CD274 (Atezolizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), ELISA

Verwendungszweck: Anti-PDL1 (atezolizumab biosimilar) mAb

Produktmerkmale: MPDL3280A,RG7446

Aufreinigung: Purified from cell culture supernatant by affinity chromatography

Güteklasse: Research Grade

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: ELISA 1:5000-10000, Flow Cyt 1:100

Kommentare:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Haltbarkeit: 12 months

Details zu CD274 (Atezolizumab Biosimilar)

Target: CD274 (Atezolizumab Biosimilar)

Andere Bezeichnung: PDL1 (Atezolizumab Biosimilar) (CD274 (Atezolizumab Biosimilar) Produkte)

Synonyme: B7-H antikoerper, B7H1 antikoerper, PD-L1 antikoerper, PDCD1L1 antikoerper, PDCD1LG1 antikoerper, PDL1 antikoerper, CD274 molecule antikoerper, CD274 antikoerper

Substanzklasse: Biosimilar

Hintergrund: Synonyms: PD-L1, CD274, B7-H1, PDCD1L1, PDCD1LG1

UniProt: Q9NZQ7